Matthew E Oster,Yanxu Yang,Caroline Shi,Susan Anderson,Jessica Knight,Logan G Spector,Osamah Aldoss,Charles E Canter,Mansi Gaitonde,Gurumurthy Hiremath,Anitha John,Deborah J Kozik,Bradley S Marino,Kimberly E McHugh,David Overman,Geetha Raghuveer,James Louis St,Jeffrey P Jacobs,Michelle Gurvitz,Grace Smith,J'Neka S Claxton,Kristina Kuo,Jessica M Flores,Romie N Velani,Amanda Thomas,Ann Mertens,Mason Basler,Violet Carey,Charlotte Gavalas,Madison Johnson,Anita Mathews,Jennifer Nelson,Katrin O'Grady,Emily Riley,Michelle Roesler,Amber Sykes,Daniel Young,Lazaros K Kochilas

Abstract:Background: With improved survival of adults with congenital heart disease (CHD) comes a need to understand the lifelong outcomes of this population. The aim of this paper is to describe the rationale and design of Congenital Heart Disease Project to Understand Lifelong Survivor Experience (CHD PULSE), a study to determine long-term medical, neurocognitive, and psychosocial outcomes among adults with a history of intervention for CHD and to identify factors associated with those outcomes. Methods: CHD PULSE is a cross-sectional survey conducted from September 2021 to April 2023 among adults aged 18 and older with a history of at least 1 intervention for CHD at 1 of 11 participating U.S. centers in the Pediatric Cardiac Care Consortium. Participants with CHD were asked to complete a 99-question survey on a variety of topics including: demographics, surgeries, health insurance, health care, heart doctors, general health, height and weight, education and work history, reproductive health (for women only), and COVID-19. To construct a control group for the study, siblings of survey respondents were invited to complete a similar survey. Descriptive statistics for demographics, disease severity, center, and method of survey completion were computed for participants and controls. Comparisons were made between participants and non-participants to assess for response bias and between CHD participants and sibling controls to assess for baseline differences. Results: Among the 14,322 eligible participants, there were 3,133 respondents (21.9%) from 48 U.S. states with surveys returned for inclusion in the study. Sibling contact information was provided by 691 respondents, with surveys returned by 326 siblings (47.2%). The median age of participants was 32.8 years at time of survey completion, with an interquartile range of 27.2 years to 39.7 years and an overall range of 20.1 to 82.9 years. Participants were predominantly female (55.1%) and of non-Hispanic White race/ethnicity (87.1%). There were no differences between participants and non-participants regarding severity of CHD. Compared to nonparticipants, participants were more likely to be female, of older age, and be of non-Hispanic White race/ethnicity. Enrolled siblings were more likely to be female and slightly younger than participants. Conclusions: With surveys from 3,133 participants from across the U.S., CHD PULSE is poised to provide keen insights into the lifelong journey of those living with CHD, extending beyond mere survival. These insights will offer opportunities for informing strategies to enhance and improve future outcomes for this population of patients.

Abstract 9409: Risk Factors and Outcomes Associated With Loss of Follow-Up in Children With Congenital Heart Disease

Risk Factors and Outcomes Associated with Gaps in Care in Children with Congenital Heart Disease

Disparities in Loss to Follow-Up Among Adults With Congenital Heart Disease in North Carolina

Health System Encounters after Loss to Cardiology Follow-up among Patients with Congenital Heart Disease

Discontinuity of Cardiac Follow-Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta-Analysis

Loss to Specialized Cardiology Follow-Up in Adults Living with Congenital Heart Disease

Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure

Evaluating Long-Term Outcomes of Children Undergoing Surgical Treatment for Congenital Heart Disease for National Audit in England and Wales

Abstract 13113: Health-Related Quality of Life After Neonatal Treatment of Symptomatic Tetralogy of Fallot: Insights From the Congenital Cardiac Research Collaborative

Abstract 10403: Residual Lesion Severity is Associated With Adverse Neurodevelopmental Outcomes in Young Children With Congenital Heart Disease

Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience

Preschool Neurodevelopmental Outcomes in Children with Congenital Heart Disease

Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study

Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients under Follow-Up at a Large Tertiary Centre

Influence of cardiac diagnosis on outcomes of pediatric heart-lung transplantation

Disparities in healthcare utilization: an analysis of disease specific and patient level factors in a Congenital Diaphragmatic Hernia clinic

Contemporary prenatal diagnosis of congenital heart disease in a regional perinatal center lacking onsite pediatric cardiac surgery: obstetrical and neonatal outcomes

Determinants of Outpatient Clinic Attendance Amongst Adults with Congenital Heart Disease and Outcome.

Abstract 11615: The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy

Risk Factors of Long-Term Sequelae After Transcatheter Closure of Perimembranous Ventricular Septal Defect in Young Children

Racial and Ethnic Disparities in Health Care Usage and Death by Neighborhood Poverty Among Individuals With Congenital Heart Defects, 4 US Surveillance Sites, 2011 to 2013